RADX Radiopharm Theranostics Limited

NASDAQ
$1.48

Radiopharm Theranostics Limited (RADX) is expected to report earnings on July 29, 2025, before the market open.

Earnings Date
1st Quarter, Sep 2026
Jul 29
Tuesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Radiopharm Theranostics Limited

Radiopharm Theranostic is a clinical-stage biopharmaceutical company focused on developing oncology radiopharmaceuticals for areas of high unmet medical need. Radiopharm Theranostic is based in SYDNEY.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.